Negative mood changes during hormone replacement therapy: A comparison between two progestogens

American Journal of Obstetrics and Gynecology

Volumn 183, Issue 6, 2000, Pages 1419-1426

  Björn, Inger ^a   Bixo, Marie ^a   Nöjd, Karin Strandberg ^a   Nyberg, Sigrid ^a   Bäckström, Torbjörn ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adverse effects; Hormone replacement therapy; Mood; Negative side effects; Progestogen

Indexed keywords

ESTRADIOL; FOLLITROPIN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENSTRUAL CYCLE; POSTMENOPAUSE; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL;

EID: 0034519549     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.107781     Document Type: Article

References (26)

1. Drug-related negative side effects is a common reason for poor compliance in hormone replacement therapy
2. Effects of hormone replacement therapy on endometrial histology in postmenopausal women
3. A longitudinal study of birth control and pregnancy outcome among women in a Swedish population
4. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestogen postmenopausal replacement therapy
5. The effect of norethisterone in postmenopausal women on oestrogen therapy: A model for the premenstrual syndrome
6. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women
7. A meta-ananalysis of the effect of hormone replacement therapy upon depressed mood
8. The impact of different doses of estrogen and progestin on mood and sexual behaviour in postmenopausal women
9. Mood changes and menstrual symptomes with different gestagen/estrogen combinations
10. Oral contraceptives in premenstrual syndrome: A randomized comparison of triphasic and monophasic preparations
11. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects
12. Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects
13. The symptomatology of progestogen intolerance
14. Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women
15. A randomized, double-blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapy
16. Progestogen addition during oestrogen replacement therapy: Effects on vasomotor symptoms and mood
17. Treatment of premenstrual syndrome with gonadotrophin-releasing hormone agonist in a low dose regimen
18. Luteal phase estradiol relates to symptom severity between patients with premenstrual syndrome
19. Climacteric complaints as influenced by progesterons
20. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: Study on serum pregnenolone, pregnenolone sulfate, 5-alpha-pregnane-3, 20-dione and 3-alpha-hydroxy-5 alpha-pregnan-20-one
21. Blood serotonin levels in postmenopausal women: Effects of age and serum oestradiol levels
22. Estrogen augments serotoninergic activity in postmenopausal women
23. Influence of norethisterone acetate and estradiol on the serotonin metabolism of postmenopausal women
24. Serotonin metabolite excretion after postmenopausal estradiol therapy
25. Diagnosis of premenstrual tension syndrome: Description and evaluation of a procedure for diagnosis and differential diagnosis
26. Relationships of serum estradiol levels, menopausal duration and mood during hormonal replacement therapy